Optomed Plc
Annual Reports

YEAR 2022

Optomed in brief

Optomed is a Finnish medical technology company and a leading manufacturer of handheld fundus cameras and screening software. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of various diseases, such as rapidly increasing diabetic retinopathy. Optomed has offices in Finland, the US and China and the company’s products are sold via various sales channels in over 60 countries globally.


Focus on the United States

The focus of Optomed’s business has shifted to the West.

“Looking to the future, our focus is especially on the United States, the FDA approval process for the Aurora AEYE AI camera, and introducing new products to the market.”

Seppo Kopsala

Key figures 2022

Net sales 2022


EUR, million

Gross margin



Adjusted EBITDA


EUR, million

Equity ratio